Intrathecal Treatment with the Anti-Phosphorylcholine Monoclonal Antibody TEPC-15 Decreases Neuronal Damage in Experimental Pneumococcal Meningitis

Publisher: Karger

E-ISSN: 1421-9794|58|3|212-216

ISSN: 0009-3157

Source: Chemotherapy, Vol.58, Iss.3, 2012-07, pp. : 212-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract